4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-20-000988
Options or other derivatives
- President and CEO acquired 190,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
KIDRON NADAV · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-01-08 | Grant or award : show line 1 in the form Stock Option (right to buy) | +190,000 | 190,000 | D |
Loading xslF345X03/ownership.xml…